http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102034243-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-548 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-549 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-08 |
| filingDate | 2017-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102034243-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating pulmonary arterial hypertension comprising epidithiodioxopiperazine compound or its derivatives, or pharmaceutically acceptable salts thereof |
| abstract | The present invention relates to epidithiodioxopiperazine (ETP) compounds or derivatives thereof; Or it relates to a pharmaceutical composition for the prevention or treatment of pulmonary arterial hypertension comprising a pharmaceutically acceptable salt thereof. |
| priorityDate | 2016-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.